These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9655259)

  • 41. Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease.
    Grosman H; Fabre B; Lopez M; Scorticati C; Lopez Silva M; Mesch V; Mazza O; Berg G
    Aging Male; 2016; 19(1):40-5. PubMed ID: 26526283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial prostate-specific antigen measurements in men with clinically benign prostatic hyperplasia during a 12-month placebo-controlled study with terazosin. HYCAT Investigator Group. Hytrin Community Assessment Trial.
    Roehrborn CG; Oesterling JE; Olson PJ; Padley RJ
    Urology; 1997 Oct; 50(4):556-61. PubMed ID: 9338731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
    Rannikko S; Adlercreutz H
    Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of transurethral resection on serum free/total prostate-specific antigen levels in patients with benign prostatic hyperplasia.
    Cetinkaya M; Ulusoy E; Aki T; Koşan M; Kundak C; Aydos MM; Gökkaya S
    Urology; 1999 Jan; 53(1):118-20. PubMed ID: 9886599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel model to predict positive prostate biopsy based on serum androgen level.
    Ujike T; Uemura M; Kawashima A; Nagahara A; Fujita K; Miyagawa Y; Nonomura N
    Endocr Relat Cancer; 2018 Jan; 25(1):59-67. PubMed ID: 29046289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How do patients with familial benign prostatic hyperplasia differ clinically from those with sporadic benign prostatic hyperplasia?
    Oztekin CV; Oztürk B; Taş M; Uğurlu O; Cetinkaya M
    Urol Int; 2006; 76(4):332-4. PubMed ID: 16679835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between serum prostate-specific antigen and calculated epithelial volume.
    Fukatsu A; Ono Y; Ito M; Yoshino Y; Hattori R; Gotoh M; Ohshima S
    Urology; 2003 Feb; 61(2):370-4. PubMed ID: 12597950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age and total and free prostate-specific antigen levels for predicting prostate volume in patients with benign prostatic hyperplasia.
    Coban S; Doluoglu OG; Keles I; Demirci H; Turkoglu AR; Guzelsoy M; Karalar M; Demirbas M
    Aging Male; 2016 Jun; 19(2):124-7. PubMed ID: 26872869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the addition of estrogen to medical castration on prostatic size, symptoms, histology and serum prostate specific antigen in 4 men with benign prostatic hypertrophy.
    Levine AC; Kirschenbaum A; Droller M; Gabrilove JL
    J Urol; 1991 Sep; 146(3):790-3. PubMed ID: 1714969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism.
    Bosch JL; Hop WC; Bangma CH; Kirkels WJ; Schröder FH
    Prostate; 1995 Nov; 27(5):241-9. PubMed ID: 7479391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Asymptomatic prostatic inflammation in men with clinical BPH and erectile dysfunction affects the positive predictive value of prostate-specific antigen.
    Agnihotri S; Mittal RD; Kapoor R; Mandhani A
    Urol Oncol; 2014 Oct; 32(7):946-51. PubMed ID: 24996777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of feminization in male patients with non-alcoholic liver cirrhosis: role of sex hormone-binding globulin.
    Maruyama Y; Adachi Y; Aoki N; Suzuki Y; Shinohara H; Yamamoto T
    Gastroenterol Jpn; 1991 Aug; 26(4):435-9. PubMed ID: 1916151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH; Hong SJ; Cho JS; Seong DH
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia.
    Stone NN; Clejan SJ
    J Androl; 1991; 12(6):376-80. PubMed ID: 1722793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
    Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
    Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer.
    Semjonow A; Hamm M; Rathert P; Hertle L
    Br J Urol; 1994 May; 73(5):538-43. PubMed ID: 7516808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.